Follow the BioAge Labs, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares trade on the US market, under the authority of SEC (Form 4). Market capitalisation: €480.1m. The latest transaction was reported on 1 July 2026 (Levée d'options). Among the most active insiders: Barton Shane. Every trade is free.
33
Insider Decl.
n/a
Thresholds
€2m
3 ops.
Buy Volume
€4m
4 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate BioAge Labs, Inc. Buy (bullish), based on 8 analysts. Average price target: US$35.63.
33Σ signal
Buys €2m€4m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
18,000 shares@ US$6.5719.6% of flowCommon StockSEC:0001210905-25-000006:0
25 of 33 declarations
Acerca de BioAge Labs, Inc.
BioAge Labs, Inc. es una empresa de biotecnología centrada en el desarrollo de terapias para prolongar la vida útil, atacando los mecanismos del envejecimiento. Cotiza en el mercado XNAS.